INSIGHTS ON DRUG DEVELOPMENT

• Tablet Manufacturing Technologies For Solid Drug Formulation

  Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.

• Transforming Research Through Lab Automation

  Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.

• Solving Bioavailability Challenges In bRo5 Drugs

  Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.

• Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication

  Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.

• API Solubility And Dissolution Enhancement Via Formulation

  6/4/2025

  Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.

• How Isogenic Organ-Chips Are Transforming The Future Of Research

  6/25/2026

  Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

• Studying The Spatial Architecture Of Glioblastoma

  3/24/2025

  Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

• Accelerate Your pDNA And mRNA Process Development

  11/13/2025

  Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

• Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development

  8/14/2026

  The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.